Categories
Market Updates

Candidiasis Therapeutics Market Therapeutic Survey Reviews, Analysis 2021 |Basilea Pharmaceuticals, Astellas, Ferrer Internacional – X herald

Market Insights Reports delivers key insights on the Global Candidiasis Therapeutics market in its latest report titled, “Candidiasis Therapeutics Market – Growth, Trends, And Forecasts (2020 – 2025)” provides an in-depth analysis of key players strategies, market growth, product demand, growth factors, technological innovations, regional outlook and global dynamics which includes drivers, challenges, and opportunities dominant in the industry. This Market study provides comprehensive data that enhances the understanding, scope, and application of this report.

Get a Sample PDF Copy of the Latest Research on Candidiasis Therapeutics Market 2021:

https://www.marketinsightsreports.com/reports/10192357417/candidiasis-therapeutics-market-growth-trends-and-forecasts-2020-2025/inquiry?mode=69

Top Key Players in the Global Candidiasis Therapeutics Market: Basilea Pharmaceuticals, Astellas, Ferrer Internacional, Pacgen Biopharmaceuticals, NovaDigm Therapeutics, Pevion Biotech, Amplyx Pharmaceuticals Inc., Biomar Microbial Technologies, Cidara Therapeutics Inc., Novabiotics Limited

The candidiasis therapeutics market is expected to witness rapid growth due to the increase in the number of patients affected by candidiasis infection, an increase in the susceptible immune-compromised patient pool, and growing awareness for candidiasis infection.

There has been an increase in the number of patients affected by candidiasis infection in the developing markets, which may boost the overall market growth over the forecast period. The Center for Disease Control and Prevention (CDC) estimates that approximately 46,000 cases of healthcare-associated invasive candidiasis occur each year, in the United States. CDC reports that the 30-day all-cause (crude) mortality among people with candidemia is approximately 30%. However, as people who develop invasive candidiasis typically have pre-medical conditions, it is generally ambiguous to determine the proportion of deaths directly attributable to the infection. This increase in the number of patients has helped in spurring the growth of the overall market. The increasing urbanization and rising hygiene awareness in developing countries may also help in the growth of the market.

Key Market Trends

Systemic Candidiasis under the Anatomy Type Segment is Anticipated to Dominate the Market during the Forecast Period

The market for systemic candidiasis is driven by the increase in the susceptible immune-compromised patient pool. Thrush occurs in approximately 2-5% of healthy newborns and affects them mainly during their first year of life. Over 1 million adult women and adolescent girls in the United States develop vaginal yeast infections each year. Therefore, the high incidence rate of candidiasis is expected to remain a major driver for the growth of the market, during the forecast period.

Regional Analysis:

The report offers an in-depth assessment of the growth and other aspects of the Candidiasis Therapeutics market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Browse Complete Report details with Table of Content:

https://www.marketinsightsreports.com/reports/10192357417/candidiasis-therapeutics-market-growth-trends-and-forecasts-2020-2025?mode=69

North America Region Holds the Largest Market Share

Due to the high investment in healthcare and awareness of diseases, the North American segment of the market studied is estimated to account for the highest market share. The candidiasis disease is growing rapidly in the United States and is not restricted to any particular region. Additionally, the North American and European regions accounted for the largest market revenue shares, due to higher awareness of the disease among individuals and the availability of better treatment. Hence, all these factors are likely to boost market growth.

This Candidiasis Therapeutics Market report addresses:

– The Market size from 2015-2020

– Expected market growth until 2025

– Forecast of how market drivers, restraints, and future opportunities will affect

– Segment and regions that will drive or lead market growth and why

– Comprehensive mapping of the competitive landscape

– In-depth analysis of key sustainability strategies adopted by market place

Customization of this Report: This report can be customized as per your needs for additional data up to 3 companies or countries or 40 analyst hours.

Please contact our sales professional (sales@marketinsightsreports.com), we will ensure you obtain the report which works for your needs.

Post Covid-19 Analysis:

All the reports that we list have been tracking the impact of COVID-19 on the market. Both upstream and downstream of the entire supply chain have been accounted for while doing this. Also, where possible, we will provide an additional COVID-19 update supplement/report to the report in Q3, please check for with the sales team.

ABOUT US:

Market Insights Reports provides syndicated market research on industry verticals including Healthcare, Information and Communication Technology (ICT), Technology and Media, Chemicals, Materials, Energy, Heavy Industry, etc. Market Insights Reports provides global and regional market intelligence coverage, a 360-degree market view which includes statistical forecasts, competitive landscape, detailed segmentation, key trends, and strategic recommendations.

Contact Us:

Irfan Tamboli (Head of Sales) – Market Insights Reports

Phone: + 1704 266 3234 | +91-750-707-8687

Email: sales@marketinsightsreports.com  | irfan@marketinsightsreports.com

Press Release Distributed by Xherald

Leave a Reply

Your email address will not be published. Required fields are marked *